SIZE XSSIZE SMSIZE MDSIZE LG

Jazz Pharmaceuticals Webinar

Rising to the Challenge of Veno-occlusive Disease (VOD): Advances in the Treatment of Post–hematopoietic Stem-Cell Transplantation (HSCT)

 

Originally presented December 13, 2017

View this webinar to gain a better understanding of VOD and treatment with Defitelio® (defibrotide sodium), the first and only approved medication for VOD with renal or pulmonary dysfunction post-HSCT.

Presenter

Katie Gatwood

Katie S. Gatwood, PharmD, BCOP
Clinical Pharmacist, Stem Cell Transplant
Vanderbilt University Medical Center
Nashville, TN

Learning Objectives:

  • Understand VOD pathogenesis and risk factors
  • Recognize VOD and the initial signs and symptoms of renal or pulmonary dysfunction
  • Discuss proposed mechanism of action, clinical efficacy, and safety of Defitelio
  • Review Defitelio dosing and administration

Attendees

This free event is open to HOPA members and non-members.
Please note: There are no certified continuing education credits approved for this program.

Listen to this webinar.

https://hopa.adobeconnect.com/p0q39iri3kd5/

 

Defitelio Indication and Important Safety Information

Please click here for full Prescribing Information for Defitelio.

 

Questions about this webinar can be directed to:
Katy Meyer, Education Manager at This email address is being protected from spambots. You need JavaScript enabled to view it. and
Emma Clawson, Education Coordinator at This email address is being protected from spambots. You need JavaScript enabled to view it..

defitel1o logo

jazz pharmaceutical logo

xs
sm
md
lg